Map | A Partnership for Children's Health Search:  Advanced Search
Home General Information Country Support Board Task Forces Resources Media Center
About the Board Last Board Meeting Members Board Reports EC reports Private Access
Printer-friendly format

Quick Reference:

What is GAVI?

GAVI Fact Sheets

Governance

Board Documents

Guidelines & Forms

Press Releases

Immunization Information

Immunization Focus
Latest Issue

GAVI Update

<<BACK TO NINTH GAVI BOARD MEETING

NINTH GAVI BOARD MEETING
Dakar, 18-19 November 2002

8 Yellow Fever

Paper (Word - 265K)

Discussion

  • The Board noted with concern that yellow fever has re-emerged as a disease of considerable public health importance in West and Central Africa and agreed that a major constraining factor for the control of this disease has been the very limited global availability of vaccine.


  • While GAVI and the Vaccine Fund currently provide yellow fever vaccine to countries for routine infant use, it would be well within the GAVI priorities of decreasing mortality from vaccine-preventable diseases to provide support for a strategy more suitable to control of yellow fever.


DECISIONS

The Board:

  • 1.1 Approved the proposal to establish a vaccine stockpile of yellow fever vaccine for preventive campaigns and emergency response activities.


  • 1.2 Requested the Vaccine Fund to provide an estimated US$ 3 million per year - for an initial period of three years (US$ 9million) - to establish a yellow fever stockpile, with performance and impact to be assessed prior to extension.


<<BACK TO NINTH GAVI BOARD MEETING

  Contact us | Guestbook | Copyrights | Text site